Quantcast

Latest Piperidines Stories

2014-07-14 08:26:29

Submission based on first head-to-head study vs. oral treatments in real world context TITUSVILLE, N.J., July 14, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking a label change that, if approved, would include new data showing significantly delayed time to relapse in patients prescribed once-monthly atypical long-acting antipsychotic INVEGA(®)...

2014-07-08 23:08:08

Matters Involving Ongoing Litigation to Be Discussed DALLAS (PRWEB) July 08, 2014 Parties involved in lawsuits regarding the anti-psychotic drug Risperdal are scheduled to meet in the Philadelphia Court of Common Pleas to hold a conference to discuss moving litigation forward, the national law firm of Baron and Budd reports. The plaintiffs in the lawsuits accuse Janssen Pharmaceuticals, as well as parent company Johnson & Johnson, of allegedly failing to properly warn users of...

2014-07-07 23:00:59

Launch of the Risperdal Lawsuits for Gynecomastia Page Comes as Hundreds of Plaintiffs Seek Compensation for Gynecomastia, a Condition Marked by the Excessive Growth of Male Breast Tissue, Which is Allegedly Caused by Risperdal. Chicago IL (PRWEB) July 07, 2014 The Oliver Law Group P.C. a harmful drug law firm, announces that they have launched a Risperdal lawsuit for Gynecomastia page in response to the growing Risperdal gynecomastia litigation underway in Pennsylvania state court. Court...

2014-07-03 23:01:07

The Firm is representing a number of Risperdal lawsuit clients in the Pennsylvania litigation who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic drug. New York, New York (PRWEB) July 03, 2014 Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) that allege the atypical antipsychotic medication caused gynecomastia (male breast growth) in men and boys continue to move forward in a mass tort proceeding underway in Pennsylvania’s...

2014-07-01 16:29:58

ALBANY, N.Y., July 1, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris Capital Partners, LLC. The transaction is consistent with AMRI's strategy to be the preeminent supplier of custom and complex drug product development and manufacturing services to the pharmaceutical industry. OsoBio is recognized as a premier contract manufacturer of highly complex...

2014-06-27 23:01:53

The Firm is representing a number of men and boys in Risperdal lawsuits that claim use of the atypical antipsychotic medication caused gynecomastia (male breast growth). New York, New York (PRWEB) June 27, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that a newly released study has linked Risperdal to low bone mass in children. The study, which was presented earlier this month at the American...

2014-06-26 23:02:56

The Firm represents Risperdal lawsuit clients in claims that allege the antipsychotic medication caused men and boys to develop gynecomastia. Rockville Centre, NY (PRWEB) June 26, 2014 The Rottenstein Law Group LLP, a national law firm that specializes in personal injury cases filed by plaintiffs with claims of harm stemming from dangerous drugs and defective medical devices, announces the launch of a new website dedicated exclusively to helping men who have been injured by the atypical...

2014-06-25 23:02:50

The Firm is representing a number of Risperdal lawsuit clients who allegedly developed gynecomastia (male breast growth) due to their use of the medication. New York, NY (PRWEB) June 25, 2014 Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) that allege the antipsychotic drug caused men and boys to develop gynecomastia, or male breast growth, continue to mount in courts around the U.S., Bernstein Liebhard LLP reports. On June 12, 2014, a 24-year-old California man filed suit...

2014-06-23 23:10:52

In Addition, The $105 Million Paxil Lawsuit Settlement with GlaxoSmithKline and Dozens of States, Prevents the Company From Paying Incentives to Drug Reps That Encourage Off-Label Use of Paxil and Other Medications. Columbus, OH (PRWEB) June 23, 2014 The Paxil birth defect lawyers at Wright & Schulte LLC note that GlaxoSmithKline has agreed to pay $105 million to resolve criminal and civil charges that it purportedly improperly marketed Paxil and other drugs. According to a report...

2014-06-23 23:01:53

The Firm is representing a number of Risperdal lawsuit clients in claims that allege use of the antipsychotic medication caused men and boys to develop gynecomastia (male breast growth). New York, New York (PRWEB) June 23, 2014 Plaintiffs in Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) pending in a mass tort litigation in Pennsylvania’s Philadelphia Court of Common Pleas have responded to a defense motion seeking to have some Risperdal gynecomastia claims dismissed on...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related